Novo Nordisk acquires Embark Biotech and enters R&D collaboration to advance obesity treatments

Novo Nordisk, a global leader in healthcare, has acquired Embark Biotech, including its lead metabolic program, in a deal that further strengthens its portfolio in ... Read More